Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study
Takanori Numata, Jun Araya, Keitaro Okuda, Hanae Miyagawa, Shunsuke Minagawa, Takeo Ishikawa, Hiromichi Hara, Kazuyoshi Kuwano Division of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanCorrespondence: Takanori Numata, Email t-numata@jikei.ac....
Main Authors: | Numata T, Araya J, Okuda K, Miyagawa H, Minagawa S, Ishikawa T, Hara H, Kuwano K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-11-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/long-term-efficacy-and-clinical-remission-after-benralizumab-treatment-peer-reviewed-fulltext-article-JAA |
Similar Items
-
Successful discontinuation of corticosteroids through remission induction therapy with benralizumab for chronic eosinophilic pneumonia
by: Yoshiro Kai, et al.
Published: (2024-01-01) -
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
by: Takanori Numata, et al.
Published: (2020-08-01) -
Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases
by: Sriram Sridhar, et al.
Published: (2019-01-01) -
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
by: Carlos Martínez-Rivera, et al.
Published: (2021-01-01) -
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
by: Giulia Scioscia, et al.
Published: (2023-06-01)